KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
Currently predicting for Mon, 29 Apr 2024

ACRX Predictions History

5 years ago
JS predicted that ACRX for 2019-02-20 is going $3.10 (-9.09%)

5 years ago
Bernard.Kalish.100493 predicted that ACRX for 2019-02-20 is going $3.01 (-5.05%)

Rank:

5 years ago
PumpTheseNumbers predicted that ACRX for 2019-02-20 is going $2.84 (-10.41%)

5 years ago
Colek77 predicted that ACRX for 2019-02-20 is going $3.90 (23.03%)

Rank:

5 years ago
JS predicted that ACRX for 2019-02-08 is going $2.34 (-6.77%)

5 years ago
David.Hughes.98391 predicted that ACRX for 2019-01-25 is going $2.53 (0.40%)

Rank:

5 years ago
Jordan.Lewis.98444 predicted that ACRX for 2019-01-23 is going $2.38 (-5.18%)

Rank:

5 years ago
JS predicted that ACRX for 2019-01-23 is going $2.56 (1.99%)

5 years ago
Robert.Schafer.83323 predicted that ACRX for 2019-01-23 is going $2.38 (-5.18%)

Rank:

5 years ago
Jeff.Kinney.97458 predicted that ACRX for 2019-01-23 is going $2.65 (5.58%)

Rank:
Click to get the best stock tips daily for free!

About AcelRx Pharmaceuticals

AcelRx Pharmaceuticals AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pai... ACRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT